INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,300 | -22.5% | 15,000 | 0.0% | 0.01% | -30.8% |
| Q2 2023 | $611,700 | +9.4% | 15,000 | 0.0% | 0.01% | +18.2% |
| Q1 2023 | $559,050 | +60.2% | 15,000 | +50.0% | 0.01% | +83.3% |
| Q4 2022 | $348,900 | -37.7% | 10,000 | 0.0% | 0.01% | -45.5% |
| Q3 2022 | $560,000 | +8.1% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $518,000 | -28.7% | 10,000 | 0.0% | 0.01% | -26.7% |
| Q1 2022 | $727,000 | -38.5% | 10,000 | 0.0% | 0.02% | -42.3% |
| Q4 2021 | $1,182,000 | -11.9% | 10,000 | 0.0% | 0.03% | -16.1% |
| Q3 2021 | $1,342,000 | -17.1% | 10,000 | 0.0% | 0.03% | -6.1% |
| Q2 2021 | $1,619,000 | +101.6% | 10,000 | 0.0% | 0.03% | +83.3% |
| Q1 2021 | $803,000 | +47.6% | 10,000 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $544,000 | +173.4% | 10,000 | 0.0% | 0.02% | +125.0% |
| Q3 2020 | $199,000 | -5.2% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $210,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |